Michelle Cheok Yien Law

Michelle Cheok Yien Law

Auto-generated profile, based on publicly available information

Michelle Cheok Yien Law

Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 December 2022 in Science Advances
Verified
Journal Article
Open access
YTyaw bia tan
yaw bia tan
DCDavid Chmielewski
David Chmielewski
MLMichelle Cheok Yien Law
Michelle Cheok Yien Law
KZKuo Zhang
Kuo Zhang
YHYu He
Yu He
DLDahai Luo
Dahai Luo
To better understand how positive-strand (+) RNA viruses assemble membrane-associated replication complexes (RCs) to synthesize, process, and transport viral RNA in virus-infected cells, we determined both the high-resolution structure of the core RNA replicase of chikungunya virus and the native RC architecture in its cellular context at subnanometer resolution, using in vitro reconstitution and in situ electron cryotomography, respectively. Within the core RNA replicase, the viral polymerase nsP4, which is in complex with nsP2 helicase-protease, sits in the central pore of the membrane-anchored nsP1 RNA-capping ring. The addition of a large cytoplasmic ring next to the C terminus of nsP1 forms the holo-RNA-RC as observed at the neck of spherules formed in virus-infected cells. These results represent a major conceptual advance in elucidating the molecular mechanisms of RNA virus replication and the principles underlying the molecular architecture of RCs, likely to be shared with many pathogenic (+) RNA viruses.

31 October 2023 in Journal of Biological Chemistry
Verified
Journal Article
Open access
MLMichelle Cheok Yien Law
Michelle Cheok Yien Law
KZKuo Zhang
Kuo Zhang
YTYaw Bia Tan
Yaw Bia Tan
TNTrinh Mai Nguyen
Trinh Mai Nguyen
DLDahai Luo
Dahai Luo
Chikungunya virus (CHIKV) nonstructural protein 1 (nsP1) contains both the N7-guanine methyltransferase and guanylyltransferase activities and catalyzes the 5' end cap formation of viral RNAs. To further understand its catalytic activity and role in virus-host interaction, we demonstrate that purified recombinant CHIKV nsP1 can reverse the guanylyl transfer reaction and remove the m7GMP from a variety of capped RNA substrates including host mRNAs. We then provide the structural basis of this function with a high-resolution cryo-EM structure of nsP1 in complex with the unconventional cap-1 substrate RNA m7GpppAmU. We show that the 5'ppRNA species generated by decapping can trigger retinoic acid-inducible gene I-mediated interferon response. We further demonstrate that the decapping activity is conserved among the alphaviral nsP1s. To our knowledge, this is a new mechanism through which alphaviruses activate the antiviral immune response. This decapping activity could promote cellular mRNA degradation and facilitate viral gene expression, which is functionally analogous to the cap-snatching mechanism by influenza virus.

13 May 2024 in Life Science Alliance
Verified
Journal Article
Open access
PDF file
ELEe-Soo Lee
Ee-Soo Lee
NNNhi Nguyen
Nhi Nguyen
BYBarnaby E Young
Barnaby E Young
HWHannah Wee
Hannah Wee
VWVanessa Wazny
Vanessa Wazny
CCChristine Cheung
Christine Cheung
Subclinical vascular impairment can be exacerbated in individuals who experience sustained inflammation after COVID-19 infection. Our study explores the prevalence and impact of autoantibodies on vascular dysfunction in healthy COVID-19 survivors, an area that remains inadequately investigated. Focusing on autoantibodies against the atypical chemokine receptor 1 (ACKR1), COVID-19 survivors demonstrated significantly elevated anti-ACKR1 autoantibodies, correlating with systemic cytokines, circulating damaged endothelial cells, and endothelial dysfunction. An independent cohort linked these autoantibodies to increased vascular disease outcomes during a median 6.7-yr follow-up. We analyzed a single-cell transcriptome atlas of endothelial cells from diverse mouse tissues, identifying enrichedAckr1expressions in venous regions of the brain and soleus muscle vasculatures, which holds intriguing implications for tissue-specific venous thromboembolism manifestations reported in COVID-19. Functionally, purified immunoglobulin G (IgG) extracted from patient plasma did not trigger cell apoptosis or increase barrier permeability in human vein endothelial cells. Instead, plasma IgG enhanced antibody-dependent cellular cytotoxicity mediated by patient PBMCs, a phenomenon alleviated by blocking peptide or liposome ACKR1 recombinant protein. The blocking peptide uncovered that purified IgG from COVID-19 survivors possessed potential epitopes in the N-terminal extracellular domain of ACKR1, which effectively averted antibody-dependent cellular cytotoxicity. Our findings offer insights into therapeutic development to mitigate autoantibody reactivity in blood vessels in chronic inflammation.

30 October 2025 in JMIR Formative Research
Verified
Journal Article
Open access
YZYichi Zhang
Yichi Zhang
MLMichelle Cheok Yien Law
Michelle Cheok Yien Law
SWSoon Keong Wee
Soon Keong Wee
BLBenjamin Sian Teck Lee
Benjamin Sian Teck Lee
BCBing Liang Alvin Chew
Bing Liang Alvin Chew
ELEdmund W J Lee
Edmund W J Lee
Background: Noncommunicable diseases, particularly hypertension, diabetes, hyperlipidemia, and obesity, are on the rise among older adults in Singapore, emphasizing the need for effective screening, monitoring, and educational interventions. The traditional health care model, relying on in-person visits to review patients, poses risks of underreported cases and missed opportunities for early interventions to manage complications. Community-based telemonitoring programs present promising opportunities to extend telehealth services to underserved populations, thereby mitigating the digital divide and addressing health inequalities. Objective: This study aimed to retrospectively evaluate the implementation of a community-based telemonitoring program, the Community Telehealth Service (CTS), developed to reduce digital barriers and raise awareness for regular health screening among older adults in the Singapore community. It also aimed to generate insights for scaling up similar telehealth initiatives in the community. Methods: This retrospective study used the (1) Implementation Research Logic Model, (2) Reach, Effectiveness, Adoption, Implementation, and Maintenance framework, and the Implementation Outcomes Framework to guide the design and evaluation of CTS’ implementation strategies. Outcomes covered implementation outcomes (reach, adoption, feasibility, and cost), service outcomes (safety and preliminary effectiveness), and user outcomes (satisfaction). Data were collected from operational statistics and structured user feedback surveys across 3 phases of implementation at different community sites. Results: Over the course of the 3 phases, CTS has reached more than 800 older individuals and 147 health ambassadors, with the participation of community organizations, health care institutions, academic collaborators, corporate sponsors, and government agencies. Operational statistics indicated that CTS was delivered consistently across 3 sites, with improving show-up rates and stable service hours. User feedback was generally positive, citing convenience, perceived value, and appreciation for health ambassador support. However, challenges were noted in referral tracking due to differing workflows across partners and in collecting user feedback, particularly in later phases where the survey was perceived as lengthy and complex for older users. Several areas for improvement were identified, such as incorporating more health assessments, providing more health-related information, and improving the referral process. Conclusions: This early-stage retrospective study suggests that community-based telehealth programs may be a feasible and acceptable approach to delivering preventive services in community settings. While initial findings are promising, further rigorous research is needed to evaluate long-term outcomes, integration with health systems, and potential for scale-up.

10 October 2026 in SSRN Electronic Journal
Verified
Preprint
Open access
LGLeonardo Giordano
Leonardo Giordano
JDJack Dorman
Jack Dorman
MLMichelle Law
Michelle Law
DFDouglas Fritz
Douglas Fritz
EGElysse Grossi-Soyster
Elysse Grossi-Soyster
PDPatrick Dolan
Patrick Dolan
Accurate quantification of viruses is essential for virology research, vaccine development, and antiviral therapeutics screening. Culture-based infectivity assays such as focus forming assays (FFA) remain widely used but are labor-intensive, operator-dependent, and difficult to scale for high-throughput applications. Although automation solutions exist, most commercial liquid-handling platforms remain cost-prohibitive for academic research laboratories. Here, we present Automated Liquid handling Infection Quantification Using OpenTrons (ALIQUOT), a modular, open-source, automated workflow for infectious virus quantification that uses the Opentrons OT-2 and Flex liquid handling systems. This platform simplifies important steps of the FFA including serial dilution, infection, overlay addition, fixation, and immunostaining, while remaining compatible with standard biosafety level 2 containment requirements. We validate ALIQUOT using dengue virus (DENV) serotypes 1–4 across two commonly used host cell lines, Aedes albopictus-derived C6/36 cells and African green monkey kidney-derived Vero cells, demonstrating consistent focus formation and reproducible infectious titer quantification across biological replicates. Automation significantly reduces hands-on time and operator exposure to infectious material while maintaining assay sensitivity. This open source workflow provides a scalable and adaptable framework for infectious virus quantification that can be easily implemented in academic laboratories. While we validated the platform using DENV, it is applicable to other viruses quantified by focus forming or plaque-based assays.